DKK1 and plasma cell myeloma: The mechanism involved that DKK1 could be secreted by multiple myeloma cells and bone marrow mesenchymal stem cells, which inhibited the classical WNT pathway, impeding osteoblast maturation and bone matrix mineralization, leading to osteolytic lesions of multiple myeloma [27].